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Background: Glutamate is the major transmitter that mediates the principal form of excitatory synaptic
transmission in the brain. It has been well established that glutamate is released via Ca2+-dependent exocytosis of
glutamate-containing vesicles in neurons. However, whether astrocytes exocytose to release glutamate under
physiological condition is still unclear.
Findings: We report a novel form of glutamate release in astrocytes via the recently characterized Ca2+-activated
anion channel, Bestrophin-1 (Best1) by Ca2+ dependent mechanism through the channel pore. We demonstrate
that upon activation of protease activated receptor 1 (PAR1), an increase in intracellular Ca2+ concentration leads to
an opening of Best1 channels and subsequent release of glutamate in cultured astrocytes.
Conclusions: These results provide strong molecular evidence for potential astrocyte-neuron interaction via
Best1-mediated glutamate release.
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Astrocytes and neurons are intimate partners in the brain.
Astrocytes respond to neuronal activity by an increase in
intracellular Ca2+ ([Ca2+]i) [1,2]. The synaptically released
neurotransmitters such as glutamate and ATP activate corre-
sponding Gαq protein-coupled receptors expressed in astro-
cytes, resulting in increase in [Ca2+]i and Ca
2+-dependent
release of gliotransmitters from astrocytes [2,3]. These glio-
transmitters in turn influence the neuronal excitability and
synaptic activities [3-8].
At the heart of this neuron-glia interaction there is
glutamate, which is released from neurons by synaptic
vesicles to mediate neuron-to-glia communication and
from astrocytes by various Ca2+-dependent mechanisms* Correspondence: cjl@kist.re.kr
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reproduction in any medium, provided the orto mediate glia-to-neuron communication [9,10]. There-
fore, understanding how astrocytes release glutamate in
Ca2+-dependent manner and how astrocytically-released
glutamate regulates neuronal synaptic activity has been a
major challenge. One line of accumulating evidence sup-
ports that astrocytes release glutamate by Ca2+- and
SNARE-dependent exocytosis mechanism [11], although
this mechanism has been recently challenged [12]. It has
been reported that glutamate released by SNARE-
dependent mechanism regulates hippocampal synapse
between perforant path afferents and granule cells [13]
or Schaffer Collateral afferent and CA1 pyramidal neu-
rons [6] through N-methyl-D-aspartic acid receptor
(NMDAR) activation. Yet, astrocytes also express a com-
bination of anion-permeable channels to move Cl- and
large anions such as glutamate across membranes in re-
sponse to specific physiological stimulations [14,15],
raising the possibility that astrocytes have a multiple glu-
tamate release mechanisms. Although astrocytes under. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anion channel-dependent glutamate release mechanism
[10,16], until now this idea has not been directly demon-
strated due to the lack of molecular evidence.
Bestrophin is the gene identified as the gene responsible
for Best's vitelliform macular dystrophy and has been
shown to encode a functional Ca2+-activated anion chan-
nel (CAAC) in nonneuronal tissue and peripheral neurons
[17]. This Bestrophin-1 channel (Best1) is directly acti-
vated by submicromolar intracellular Ca2+ concentration
and has an anion selective pore with single channel activ-
ities [17-24]. Recently, we have discovered that astrocytes
express CAAC and that Best1 encodes most of the CAAC
in astrocytes [25]. This astrocytic CAAC showed a consid-
erable permeability to large anions such as isethionate and
glutamate [25]. In addition, we have recently demon-
strated that Best1 channel mediates tonic GABA release
from cerebellar glia by a direct permeation [26]. There-
fore, we hypothesized that Best1 is the molecular identity
of Ca2+-dependent anion channel that mediates glutamate
release from astrocytes. Here we tested whether Best1 is
an alternative Ca2+-dependent glutamate release mechan-
ism in cultured astrocytes. To stimulate astrocytes more
physiologically, we activated endogenous GPCRs by appli-
cation of TFLLR [27] a selective peptide agonist of the
protease activated receptor 1 (PAR1). We demonstrate
that PAR1-induced glutamate release is mediated not by
conventional vesicular exocytosis but by an activation of



































Figure 1 PAR1 induced glutamate release is blocked by CAAC blocke
using isotope-labeled glutamate (3H-glutamate). 30 μM of TFLLR was treate
B) Bar graphs represent the averaged relative amount of released glutamat
Flufenamic acid (Flu, n=4) was pretreated to block anion channel activationResults
PAR1-induced glutamate release is mediated by CAAC
It has been suggested that hippocampal astrocytes utilize
an anion channel-dependent mechanism for Ca2+-induced
glutamate release [10,16]. To confirm the anion channel-
mediated glutamate release from astrocytes, we performed
an in vitro glutamate release assay using radioactive
isotope-labeled glutamate (3H-glutamate) in cultured hip-
pocampal astrocytes (Figure 1A) [7]. To elicit intracellular
Ca2+ increase and the subsequent release of glutamate in
astrocytes, we used TFLLR to activate PAR1. We found
that an application of TFLLR induced a significant glu-
tamate release from cultured astrocytes (Figure 1B), which
was inhibited by a pre-incubation of anion channel block-
ers, such as niflumic acid and flufenamic acid (Figure 1B)
[28]. These results suggested that astrocytes utilize anion
channel-dependent glutamate release mechanism.
Best1 mediates a Ca2+-dependent glutamate release in
cultured astrocytes
We have recently demonstrated that Best1 channel is
activated by intracellular Ca2+ (EC50 = 150 nM) with con-
siderable permeability to GABA [26]. To test whether
Ca2+- induced glutamate release is also mediated by Best1
in native astrocytes, we adopted a gene silencing tool
using the short hairpin RNA (shRNA) specifically targeted
to mouse Best1 transcript [25,26]. We recorded whole cell
currents in cultured astrocytes under gramicidin-D perfo-
rated patch configuration (Figure 2B). We found the
significant Ca2+-induced conductance carried by the effluxTFLLR 
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Figure 2 Development of Best1 specific genetic tools. A) Left; Topology model of Bestrophin suggested by Tsunenari et al [17]. Blue circle
indicates amino acid position of Best1 pore mutant (W93C). Red square indicates target amino acids for Best1 shRNA. Right; nucleotide and
amino acid sequences of Best1 shRNA target. Nucleotide sequence differences from wild type Best1 (Best1 WT) and shRNA insensitive Best1
(Best1(sh insens)) were highlightened. B) Schematic diagram for perforated-patch-current recording from cultured astrocytes. C) Representative
perforated-patch-current recording from Best1-shRNA and Best1 (sh insens) or Best1-shRNA and shRNA insensitive pore mutant Best1
(Best1-W93C (sh insens)) expressing cultured astrocytes. The current responses were recorded in response to a voltage ramp command
(from -100 to +100 mV, 1 s duration, 0.2 Hz; Vh of -70 mV) before and after 30 μM TFLLR treatment. D) The bar graph summarizes the mean
current amplitude at Vh = -70 mV ± s.e.m (*p < 0.05, **p < 0.01, unpaired t-test). Among 13 recorded astrocytes which expressed Best1-shRNA and
Best1 (sh insens), only 5 cells showed comparable currents. And a big current recorded in an astrocyte expressing Best1-shRNA and Best1-W93C
(sh insens) was eliminated in the bar graph. Numbers of determinations are indicated on the bar graph.
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shRNA. Silencing the Best1 gene via specific shRNA for
Best1 significantly eliminated PAR1 induced whole-cell
current in cultured astrocytes. This effect was fully res-
cued by the cotransfection of Best1-shRNA, along with a
shRNA-insensitive form of Best1 (Figure 2C and D). How-
ever, the addition of a pore mutation at position 93, from
tryptophan to cystein (Best1-W93C sh insens) [29] failed
to rescue the current (Figure 2C and D). These resultsindicate that pore of Best1 channel is responsible for the
permeation of anions such as Cl- and glutamate. We fur-
ther tested the effect of Best1-shRNA on glutamate release
using conventional high-performance liquid chromatog-
raphy (HPLC) from the solution samples collected after
5 min application of TFLLR in cultured astrocytes. In this
experiment, we firstly prepared astrocytes with the same
cell number of cells that were transfected with Sc-shRNA
or Best1-shRNA. Since we found that Best1-shRNA did
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shown), we assumed that total number of astrocytes in each
sample after transfection of Sc-shRNA or Best1-shRNA
should be similar. We found a decrease in glutamate release
by Best1-shRNA using HPLC method (Figure 3). These
results indicate that the Best1 channel is the molecular
identity of glutamate permeable CAAC and suggest that
the Best1 channel might be the molecular machinery for
Ca2+-dependent glutamate release from astrocytes.
To independently confirm the glutamate release by
HPLC method, we tested the effect of Best1-shRNA on
glutamate release using fluorescence resonance energy
transfer (FRET) based glutamate sensor. The released glu-
tamate was monitored using a glutamate-sensing fluores-
cent reporter, GluSnFR, which senses glutamate by
changing the ratio of FRET from CFP to YFP upon glutam-
ate binding [30] (Figure 4A). The concentration-response
curve for glutamate on the sensor was within the range of
estimated glutamate release from a single astrocyte in
culture (~10-6 M) [7] (Figure 4C and 4D). The calculated
EC50 of glutamate was ~25.57 μM (Figure 4D). We
observed that a brief pressure application of TFLLR caused
a long lasting glutamate release as indicated by the relative
change in FRET ratio (Figure 4B and 4E). The amount of
glutamate release was on average significantly lower in the
astrocytes expressing Best1-shRNA (Figure 4E, red sym-
bols) than those expressing control scrambled shRNA
(Figure 4E, black symbols). We found a similar degree of
decrease in glutamate release by Best1-shRNA using the
FRET based glutamate imaging, as compared to HPLC
method (Figures 3C and 4F). Co-application of TFLLR and
niflumic acid or treating the cells with BAPTA-AM, signifi-
cantly reduced the glutamate release from astrocytes
(Figure 4E and 4F).
PAR1 induced glutamate release is not due to vesicular
release
We noted that the amount of released glutamate was
not completely inhibited by gene-silencing of Best1






Figure 3 HPLC detection of TFLLR-induced glutamate release from as
glutamate release from scrambled-shRNA (Sc-shRNA) or Best1-shRNA expre
(blue) and B1-shRNA (red) infected astrocytes. C) Bar graphs show the averhave other Best1-independent mechanisms for glutamate
release such as vesicular exocytosis. It is possible that
Best1-shRNA affects the expression level of other genes
involved in vesicular release. To address this possibility,
we performed semi-quantitative RT-PCR analysis of
cultured astrocytes with Best1-shRNA. Best1-shRNA
showed a knock down efficiency for Best1 of over 90%
while not affecting the expression level of other known
genes such as Syt4 (Synaptotagmin4), Munc18-1, Vamp2
(Vesicle-associated membrane protein 2) involved in
vesicular release (Figure 5A). We also tested whether
inhibiting vesicular release machinery affects the glutam-
ate release by using FRET based glutamate imaging. We
found that the pretreatment with Conconomycin A
(preventing vesicular glutamate release by inhibiting
vesicular hydrogen ATPase, [31]) and Tetanus toxin
(interfering all vesicular releases by inhibiting fusion of
vesicles, [32]) slightly but not significantly reduced
TFLLR-induced glutamate release from cultured astro-
cytes (Figure 5B and 5C). Consistent with these results,
hyperosmotic challenge, which is known to cause a Ca2+
independent exocytosis of glutamate containing releas-
able vesicles, did not show any significant increase in
glutamate release (Figure 5B and 5C). Taken together,
PAR1-induced glutamate release is not mediated by
vesicular exocytosis in cultured astrocytes.
Discussion
In this study we report the direct evidence of anion
channel-mediated glutamate release mechanism. We pro-
vide a series of evidence for Ca2+-activated, Best1-mediated
glutamate release from astrocytes. For example, the select-
ive gene silencing of astrocytic Best1 channels significantly
reduced GPCR-induced and Ca2+-dependent glutamate
release from astrocytes as measured by HPLC detection of
glutamate from cultured astrocytes (Figure 3), and by
FRET glutamate sensor in cultured astrocytes (Figure 4).
The FRET based glutamate sensor has been well-
characterized in the previous report [30]. In that report it
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Figure 4 Best1-mediated glutamate release from cultured astrocytes by using glutamate-sensitive FRET sensor, GluSFnR. A) Schematic
diagram of principles of FRET-based glutamate sensor and imaging. Released glutamate from astrocyte binds to glutamate binding motif of
GluSnFR (glutamate FRET sensor), resulting in decrease of FRET between CFP and YFP or increased CFP/YFP ratio. B) Representative FRET images
from GluSnFR-expressing cultured astrocytes processed by CFP/YFP emission ratio. The white bar shown at 0 s image indicates the puff of TFLLR
(500 μM, 100 msec). C) Astrocytic GluSFnR responses (CFP/YFP ratio change) by respective puff-treated extracellular glutamate concentration at
the time point indicated by an arrow. D) The graph showing the relationship between glutamate concentration and peak value of relative
CFP/YFP ratio. The calculated EC50 was ~ 25.57 μM. E) The graph shows the averaged relative CFP/YFP ratio values from time-lapse imaging using
GluSFnR expressing-cultured astrocytes. Scrambled shRNA-expressing astrocytes (Sc-shRNA); Best1-shRNA-expressing astrocytes (B1-shRNA); naïve
astrocytes pretreated with BAPTA-AM (BAPTA; 30 μM); naïve astrocytes pretreated with niflumic acid (NFA; 100 μM); naïve astrocytes treated with
recording buffer puff (Buffer puff). F) Bar graph representing averaged relative CFP/YFP ratio (analyzed during the period indicated by the gray box
in Figure 1F). *p < 0.05, **p < 0.01 vs. Sc-shRNA-expressing group. Numbers on each bar indicate number of cells from at least three independent
culture batches.
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and high selectivity toward glutamate with no apparent
change in ratio with APV, NBQX, NMDA, KA, AMPA,
etc. [30]. We performed a calibration experiment by meas-
uring glutamate EC50 in our imaging system and experi-
mental conditions. Our calibration results showed that the
FRET-based glutamate sensor in cultured astrocyte can be
useful in detecting micromolar and submicromolar con-
centrations of released extracellular glutamate from a sin-
gle astrocyte.Until now, it has been proposed that glutamate could
be released from astrocytes through multiple routes, in-
cluding Ca2+- and SNARE-dependent vesicular exocyt-
osis, the reversal action of glutamate transporters,
transportation by cystine-glutamate antiporter, and per-
meation through channels or receptors, such as P2X7
receptor, volume regulated anion channel (VRAC), or
gap junction hemichannel [33]. Among these, the
molecular mechanism of Ca2+-dependent glutamate
release has been extensively studied mainly because the
A B
C
Figure 5 TFLLR-induced glutamate is not by vesicular exocytosis. A) To test whether Best1–shRNA affects the expression of exocytotic
protein transcripts, mRNA expression levels of several endogenous vesicular machineries such as Syt4, Munc18-1, Vamp2 were analyzed from
cultured astrocytes expressing Best1–shRNA or scrambled shRNA at least for 72 h. PCR cycles for Best1, Syt4 (Synaptotagmin4), Munc18-1, Vamp2
(Vesicle-associated membrane protein 2), and GFAP were 35, 35, 30, 30, and 25, respectively. B) Time-lapse imaging of relative CFP/YFP ratio from
GluSFnR-expressing cultured astrcytes plotted as mean ± sem. Arrowhead indicates the time point of 500 μM TFLLR puff. Naïve astrocytes (Control);
naïve astrocytes pretreated with 0.5 mM concanamycin (Conc.A; 2 hrs); naïve astrocytes pretreated with 10 nM tetanus toxin (TeNT; ~14 hrs); naïve
astrocytes treated with hyperosmotic solution puff (Hyper). Bar graphs represent the averaged relative CFP/YFP ratio from 30 sec to 70 sec.
Numbers of cells from at least two independent culture batches are indicated on the bar graph.
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neuronal activity is one of the most important physio-
logical readout of neural activity [3,5,7,10]. Numerous
studies have proposed the SNARE-dependent exocytosis
of glutamate as a potential route for astrocytic Ca2+-
dependent glutamate release. These studies demon-
strated that astrocytic glutamate release was sensitive to
exocytosis blockers or the expression of the essential
machineries for regulating Ca2+-dependent exocytosis
[33]. In addition to the vesicular mechanism, there is
multiple lines of evidence suggesting that astrocytes ex-
press a Ca2+-dependent but non-vesicular glutamate re-
lease machinery [16]. Despite its unclear molecular
identity, it has been reported that an increase in Ca2+ by
GPCR activation induces glutamate release from ast-
rocytes through osmolyte-permeable anion channels
[10,28], which are activated by intracellular Ca2+ or
increase in cell volume [16]. In our previous reports,
we observed that Best1-mediated Ca2+-activated anion
current could be induced by a host of GPCR agonists
such as mGluR1/5, P2Y, B2, S1P, and LPAR in astrocytes
[25], and that activation of those receptors elicits Ca2+-
dependent glutamate release [7]. Finally, Best1 was
demonstrated to be permeable to GABA and mediate
tonic GABA release in cerebellar glial cells [26]. Recentstudy showed that GABA is abundant in cerebellar glial
cells to be released tonically via Best1 to cause tonic inhib-
ition [34]. However, in hippocampus, GABA is not present
in glial cells; rather, Best1 might release glutamate near
synapse. Therefore, it is plausible that Best1, at least
in part, could be the downstream target of various
Gq-coupled GPCRs that signal through intracellular Ca
2+
to release glutamate in hippocampal astrocytes.
In addition to Best1 channel, other anion channels
might participate in anion channel-mediated glutamate
release as previously suggested, such as Ca2+-induced
but volume regulated osmolyte-permeable channels [16].
In fact, there are several studies showing that bestrophin
channel could be opened by both cytosolic Ca2+ and
cell volume increase [17,35], raising a possibility that
Best1-mediated glutamate release is also triggered by
Ca2+-dependent cell swelling and subsequent activation
of VRAC. However, in our previous study we demon-
strated that PAR-1 activation does not induce significant
swelling [36] indicating that Ca2+ directly initiates Best1
channel-mediated glutamate release from astrocytes.
The PAR1-induced astrocytic glutamate release was not
completely inhibited by Best1 knock-down (Figure 4).
Still, vesicular release mechanism was not involved be-
cause Best1 silencing did not affect the expression level
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and glutamate release from astrocytes was not reduced
by treatment with Conconomycin A or Tetanus toxin
(Figure 5B). There is a possibility that other ion channels
that are independent of Best1 channel might participate
in PAR1-induced glutamate release from astrocytes.
We utilized the native GPCR, PAR1, which has been ex-
tensively used in numerous studies to selectively activate
astrocytes. Even though PAR1 is expressed in a subset of
dentate granule cells [37], PAR1 has been shown to be
expressed exclusively in astrocytes in human and rodent
CA1 hippocampus [7,38,39], as well as in the nucleus of
solitary tract [40] to mediate neuron-glia interaction.
Therefore, the source of PAR1-induced glutamate is
most likely astrocyte, as a direct consequence of increase
[Ca2+]i. Although there is no direct evidence of how PAR1
is activated in the physiological situation up to now, the
recent study demonstrated that tPA-plasmin pathway is
an endogenous PAR1 agonist [41], suggesting that physio-
logical PAR1 activation is initiated by the activation of
tPA-plasmin pathway in physiological condition such as
synaptic plasticity [42,43].
In summary, we reveal a novel anion channel-mediated
glutamate release mechanism in cultured astrocytes. The
ideas and tools developed in this study should prove to be
helpful in understanding the physiological role of glutam-
ate release mechanism and its functional significances.
Methods
Primary astrocyte culture
Cell culture of mouse astrocytes was performed as previ-
ously described [7]. The cerebral cortex from P0 ~ P3
postnatal mice was dissected free of adherent meninges,
minced and dissociated into single cell suspension by
trituration. Dissociated cells were plated onto 12 mm
glass coverslips coated with 0.1 mg/ml poly D-lysine.
Cells were grown in DMEM supplemented with 25 mM
glucose, 10% heat-inactivated horse serum, 10% heat-
inactivated fetal bovine serum, 2 mM glutamine, and
1000 units ml-1 penicillin-streptomycin. Cultures were
maintained at 37°C in humidified 5% CO2-containing
atmosphere.
Glutamate FRET imaging
In FRET-based glutamate imaging experiments, pDisplay-
GluSnFR vector [30] was electroporated alone or with
pSicoR-scrambled-shRNA or pSicoR-Best1-shRNA vector
into cultured astrocytes (MicroPorator; Digital Bio, Korea).
After 48 ~ 72 hour expression, FRET imaging was per-
formed under a microscope (BX50WI; Olympus) equipped
with xenon lamp with 436/20 excitation filter (D436/20x fil-
ter; Chroma). The emission beam was split with a DualView
(Optical Insights) with a CFP/YFP filter set (OI-05-EX),
recorded by EM-CCD camera (ANDOR IXON). ImagingWorkbench software (INDEC BioSystems) was used for
image acquisition and offline image analysis. TFLLR puff
(TFLLR-NH2; Peptron, Korea; 500 μM) was made by using
picospritzer-assisted positive pressure (~100 ms). The
amount of released extracellular glutamate was described as
ratio between the emission intensity of CFP and YFP (CFP/
YFP), which was divided by baseline CFP/YFP ratio (relative
CFP/YFP ratio).
Radioactivity glutamate release assay
In vitro glutamate assay using 3H-labelled glutamate was
performed as described previously [7]. Astrocytes were
loaded with 0.5 μm l-[3H]glutamate for 60 min by
adding 1 μm of 1 mCi ml−1 l-[3H]glutamate stock solu-
tion to 2 ml of culture medium. The cultures were pre-
incubated for 30 min with 1 mm amino-oxyacetic acid
and 0.5 mm methionine sulfoximine before adding [3H]
glutamate, and during the loading to inhibit the metab-
olism of glutamate to glutamine and other metabolites
[44]. Cells were washed with external solution 3 times.
In some experiments, the external solution was supple-
mented with 50 μm l-transpyrrolidine-2,4-dicarboxylic
acid (trans-PDC) to block glutamate transporter, a max-
imally effective concentration (6× IC50 of 4–8 μm; [45])
that is well below that suggested to stimulate heter-
oexchange (0.2 mm; [46,47]). Agonists were added to
external solution for 6 min and the experiment was ter-
minated by collection of the solution. Each experimental
run included the control condition in which no agonist
was added. Six replicates were obtained for each drug
condition. For analysis, the average radioactivity count
was obtained from six replicates for each condition and
compared to the average of control.HPLC analysis for glutamate release
The Cortical primary astrocytes were cultured in 60 mm
dishes for HPLC analysis. TFLLR (30 μM) was used to in-
duce glutamate. Prior to TFLLR treatment, astrocytes were
washed with PBS three times. For gene silencing experiment,
Lentivirus containing Scrambled or Best1-shRNA was trea-
ted to cells and incubated for 48 hrs. The amino acid content
was derivatized with o-phthaldialdehyde (OPA) and detected
using UV (DAD) detection [48]. The OPA derivatized sam-
ples by programmed autosampler were injected on Zorbax
Eclipse Plus C18 column with detection at 338 nm (a refer-
ence = 390 nm). Mobile phase A was 40 mM Na2HPO4 pH
7.8, and B was acetonitrile/methanol/water (45:45:10, v/v/v).
The flow rate was 2 mL/min with a gradient condition that
allowed for 1.9 min at 0% B and raised to 26% B at a 12.5
min-step. Then washing at 100% B and equilibration at 0% B
was performed in a total retention time of 15 min. Reagents
of OPA derivatization and all equipments for HPLC analysis
were obtained from Agilent Technologies.
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Best1-shRNA and lentivirus production were performed
as previously described ([49], Virus facility, KIST). Best1
shRNA-insensitive pore mutant (Best1-shRNA insens
W93C) was generated by using PCR-based site-directed
mutagenesis kit (Stratagene, Cedar Creek, TX, USA).
Electrophysiology
The extracellular recording solution for perforated patch
clamp recording was comprised of (in mM) 150 NaCl,
10 HEPES, 3 KCl, 2 CaCl2, 2 MgCl2, 5.5 glucose, at
pH 7.3. The internal solution contained 25 μg/ml grami-
cidin D and (in mM) 75 Cs2SO4, 10 NaCl, 0.1 CaCl2,
and 10 HEPES, at pH 7.1. Pipette resistances ranged
from 5 to 8 MΩ. It took 20 to 30 min to achieve accept-
able perforation, with final series resistances ranging
from 15 to 40 MΩ. Current voltage curves were estab-
lished by applying 100- , 200-, or 1000 ms duration volt-
age ramps from –100 to +100 mV. Data were acquired
by an Axopatch 200A amplifier controlled by Clampex
9.2 via Digidata 1322A data acquisition system (Axon
Instruments, Union City, CA, USA). Experiments were
conducted at room temperature (20 ~ 24°C).Reverse transcription-PCR
Total RNA was prepared from cultured astrocyte from
postnatal day 0–3 mice using Trizol reagent (Invitrogen).
cDNA was synthesized using Super Script III reverse
transcriptase (Invitrogen). The reverse transcription
(RT)-PCR primers used to check expression of Best1,
Syt4 (Synaptotagmin4), Munc18-1, Vamp2 (Vesicle-asso-
ciated membrane protein 2) GAPDH and glial fibrillary
acidic protein (GFAP) were as followings
; Best1 forward, 5’-AGGACGATGATGATTTTGAG- 3’
; Best1 reverse, 5’-CTTTCTGGTTTTTCTGGTTG- 3’
; Syt4 forward, 5’-AGGCCAATTCCCCTGAGAGC- 3’
; Syt4 reverse, 5’-ACCGCTTCCTTCTGCTGTGG- 3’
; Munc18-1 forward, 5’-
ACTCCGCTGACTCTTTCCAA- 3’
; Munc18-1 reverse, 5’-
GTCGGCTTTATAGGCATCCA- 3’
; Vamp2 forward, 5’-GTCACTGCCTCTGCCAAGTC- 3’
; Vamp2 reverse, 5’-GGCAGACTCCTCAGGGATTT- 3’
; GAPDH forward, 5’-
AGCTGAACGGGAAGCTCACT- 3’
; GAPDH reverse, 5’-TGCTGTAGCCAAATTCGTTG- 3’
; GFAP forward, 5’-AGAACAACCTGGCTGCGTAT-3’
; GFAP reverse, 5’-CGGCGATAGTCGTTAGCTTC-3’
Primers for Syt4, Munc18-1 and Vamp2 were designed
as previous reports [50,51]. All reactions were performed
in a programmable thermocycler (Eppendorf ).Competing interests
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